WO2009105535A1 - Transcutaneous osseointegrated device for prostheses - Google Patents
Transcutaneous osseointegrated device for prostheses Download PDFInfo
- Publication number
- WO2009105535A1 WO2009105535A1 PCT/US2009/034512 US2009034512W WO2009105535A1 WO 2009105535 A1 WO2009105535 A1 WO 2009105535A1 US 2009034512 W US2009034512 W US 2009034512W WO 2009105535 A1 WO2009105535 A1 WO 2009105535A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bone
- sleeve portion
- transcutaneous
- flange portion
- sleeve
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 87
- 210000001519 tissue Anatomy 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 17
- 239000000654 additive Substances 0.000 claims description 10
- 230000000996 additive effect Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000005094 computer simulation Methods 0.000 claims description 7
- 238000003384 imaging method Methods 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 210000003414 extremity Anatomy 0.000 description 30
- 210000003195 fascia Anatomy 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 206010033675 panniculitis Diseases 0.000 description 9
- 210000004304 subcutaneous tissue Anatomy 0.000 description 9
- 210000002435 tendon Anatomy 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 7
- 238000010894 electron beam technology Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 210000004872 soft tissue Anatomy 0.000 description 6
- 238000000576 coating method Methods 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000002131 composite material Substances 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- -1 aluminum silicates Chemical class 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 2
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 2
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 2
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 2
- 108010066486 EGF Family of Proteins Proteins 0.000 description 2
- 102000018386 EGF Family of Proteins Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 210000003484 anatomy Anatomy 0.000 description 2
- 229940112869 bone morphogenetic protein Drugs 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 229920002430 Fibre-reinforced plastic Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OQPDWFJSZHWILH-UHFFFAOYSA-N [Al].[Al].[Al].[Ti] Chemical compound [Al].[Al].[Al].[Ti] OQPDWFJSZHWILH-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 238000007470 bone biopsy Methods 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- XFWJKVMFIVXPKK-UHFFFAOYSA-N calcium;oxido(oxo)alumane Chemical compound [Ca+2].[O-][Al]=O.[O-][Al]=O XFWJKVMFIVXPKK-UHFFFAOYSA-N 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011151 fibre-reinforced plastic Substances 0.000 description 1
- 238000010100 freeform fabrication Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 210000001872 metatarsal bone Anatomy 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000000278 osteoconductive effect Effects 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001299 polypropylene fumarate Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 229910021324 titanium aluminide Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/28—Bones
- A61F2/2814—Bone stump caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/78—Means for protecting prostheses or for attaching them to the body, e.g. bandages, harnesses, straps, or stockings for the limb stump
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2/30749—Fixation appliances for connecting prostheses to the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/54—Artificial arms or hands or parts thereof
- A61F2/58—Elbows; Wrists ; Other joints; Hands
- A61F2/583—Hands; Wrist joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/60—Artificial legs or feet or parts thereof
- A61F2/66—Feet; Ankle joints
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/76—Means for assembling, fitting or testing prostheses, e.g. for measuring or balancing, e.g. alignment means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0077—Special surfaces of prostheses, e.g. for improving ingrowth
- A61F2002/0086—Special surfaces of prostheses, e.g. for improving ingrowth for preferentially controlling or promoting the growth of specific types of cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30331—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30433—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels, rivets or washers e.g. connecting screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3093—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth for promoting ingrowth of bone tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/5044—Designing or manufacturing processes
- A61F2002/5055—Reinforcing prostheses by embedding particles or fibres during moulding or dipping, e.g. carbon fibre composites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/50—Prostheses not implantable in the body
- A61F2/78—Means for protecting prostheses or for attaching them to the body, e.g. bandages, harnesses, straps, or stockings for the limb stump
- A61F2002/7887—Means for protecting prostheses or for attaching them to the body, e.g. bandages, harnesses, straps, or stockings for the limb stump for connecting limb exoprostheses to the stump bone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0041—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using additional screws, bolts, dowels or rivets, e.g. connecting screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00017—Iron- or Fe-based alloys, e.g. stainless steel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00407—Coating made of titanium or of Ti-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00413—Coating made of cobalt or of Co-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00419—Other metals
- A61F2310/00449—Coating made of chromium or Cr-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00419—Other metals
- A61F2310/00461—Coating made of nickel or Ni-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00419—Other metals
- A61F2310/00544—Coating made of tantalum or Ta-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00598—Coating or prosthesis-covering structure made of compounds based on metal oxides or hydroxides
- A61F2310/0061—Coating made of silicon oxide or hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00796—Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00928—Coating or prosthesis-covering structure made of glass or of glass-containing compounds, e.g. of bioglass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00958—Coating or prosthesis-covering structure made of bone or of bony tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/0097—Coating or prosthesis-covering structure made of pharmaceutical products, e.g. antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00976—Coating or prosthesis-covering structure made of proteins or of polypeptides, e.g. of bone morphogenic proteins BMP or of transforming growth factors TGF
- A61F2310/00982—Coating made of collagen
Definitions
- Various embodiments of the present invention relate to devices and methods for securing a prosthetic device to an anatomical structure and, in particular, to a transcutaneous osseointegrated device configured to be fixated to an anatomical structure and coupled to a prosthetic device.
- External prosthesis have been used to improve mobility and function of humans and animals with missing extremities. While external prosthesis may be used, they have several limitations that complicate their use and limit their benefits. For example, external prosthesis may only be fitted on limbs with relatively long stumps, place pressure on soft tissue, have a suboptimal transfer of forces during locomotion resulting from forces traveling through soft tissue, and have relatively high wear rates.
- limb prostheses particularly weight-bearing prosthetic devices (such as artificial legs and/or feet)
- fixation of limb prostheses to a bony structure typically requires the use of a transcutaneous adapter extending from the bone to an externally-located prosthetic device via an opening in the skin of the residual limb.
- Such openings may allow infection to develop in the residual limb.
- the onset of infection in such conventional systems may result in the need for the complete removal and/or replacement of the transcutaneous member.
- transcutaneous adapter that is integrated with a bone-fixation portion (such as an implantable stem and/or bone plate attached to the bone via screws)
- inpatient surgical procedures may be required to replace the entire system in an attempt to treat the infection.
- many conventional prosthetic systems provide a single, large- diameter, transcutaneous adapter that is tasked with supporting the majority of the force exerted on the suspension system as the user ambulates.
- the single transcutaneous adapter may, in some cases, be prone to failure and/or premature wear, particularly at points where the bone fixation portion is not adequately integrated with the bone.
- transcutaneous device that is configured to reduce the incidence of infection.
- transcutaneous device may be sufficiently integrated in the bone of the limb so as to provide adequate fixation.
- transcutaneous device that is adaptable to a variety of limbs.
- inventions of the present invention which, in one embodiment, provides a transcutaneous osseointegrated device for fixation of prosthetic devices.
- the device is configured to reduce the incidence of infection and promote long-term fixation with the limb.
- the device may be used for receiving various prostheses, such as a foot or hand and may be various sizes and configurations for accommodating various sized patients.
- the device includes a sleeve portion configured to receive at least a portion of a bone and be fixated to the bone and a flange portion adjacent to the sleeve portion and configured to abut the end of the limb (e.g., the bone, surrounding skin, tissue, muscles, tendons, and/or fascia).
- the flange portion has a first side facing the sleeve portion and an opposing second side.
- the device further includes a post portion extending from the second surface and configured to be coupled with a prosthetic device.
- the sleeve portion may include an opening and a thin wall such that the bone is configured to be received within the opening, and such that the thin wall provides an interface between both its interior surface and the bone and between its outer surface and the surrounding tissue.
- the flange portion may extend radially outward from the sleeve portion and the first side of the flange portion may be configured to cup the end of the bone and surrounding tissue.
- the inner surface of the sleeve may be textured, coated, and/or porous to facilitate bone fixation.
- the outer surface of the sleeve may also be textured, coated, and/or porous to promote tissue in-growth and/or on-growth.
- at least a portion of the first side of the flange may be textured, coated, and/or porous to promote in-growth and/or on-growth with the tissue.
- the sleeve portion may include a plurality of holes for receiving respective fasteners.
- the heads of the fasteners may be configured to engage the sleeve portion and lock in place using a Morse taper or thin thread.
- the fasteners may be configured to extend through the sleeve portion and into the central canal of the bone, such as for larger bones.
- the post portion may be configured for threaded engagement with the prosthetic device.
- the post portion may include a threaded surface
- the device may further include a threaded nut having a hole configured to receive a stem of the prosthetic device and engage the threaded surface of the post portion.
- the post portion may also include a tapered hole that is configured to mate with a correspondingly tapered end of the stem.
- the device may be integrally defined from a single piece of material, such as a biocompatible metal material.
- An additional embodiment provides a method for manufacturing a transcutaneous osseointegrated device for fixation of a prosthetic device to a bone and surrounding tissue of a limb.
- the method includes integrally forming a transcutaneous osseointegrated device comprising a sleeve portion, a flange portion, and a post portion using an additive manufacturing process (e.g., an energy-beam additive manufacturing process).
- the method may include imaging the limb and creating a computer model of the limb based on the imaging, wherein integrally forming comprises automatically forming the transcutaneous osseointegrated device in accordance with the computer model.
- an embodiment of the present invention provides a method for fixating a prosthetic device to a bone and surrounding tissue of a limb with a transcutaneous osseointegrated device.
- the method includes providing a transcutaneous osseointegrated device comprising a sleeve portion, a flange portion, and a post portion, positioning at least a portion of the bone within the sleeve portion such that the flange portion abuts the bone and surrounding tissue, and coupling the post portion to the prosthetic device.
- FIG. 1 is a perspective view of a transcutaneous osseointegrated device according to one embodiment of the present invention
- FIG. 2 is a perspective view of a transcutaneous osseointegrated device according to another embodiment of the present invention
- FIG. 3 is an end view of the transcutaneous osseointegrated device shown in FIG.
- FIG. 4 is cross-sectional view of the transcutaneous osseointegrated device shown in FIG. 2;
- FIG. 5 is a partial cross-sectional view of a transcutaneous osseointegrated device with a stem coupled thereto according to one embodiment of the present invention
- FIG. 6 is a partial perspective view of a transcutaneous osseointegrated device coupled to a prosthetic device according to one embodiment of the present invention
- FIG. 7 is an exploded perspective view of the transcutaneous osseointegrated device and prosthetic device shown in FIG. 6;
- FIG. 8 is a cross-sectional view of a transcutaneous osseointegrated device according to an additional embodiment of the present invention.
- FIG. 9 is a perspective view of a transcutaneous osseointegrated device installed within a tibia of a feline according to an additional embodiment of the present invention.
- FIG. 10 is a perspective view of the transcutaneous osseointegrated device of FIG.
- embodiments of the present invention generally provide a transcutaneous osseointegrated device 10 for fixation of a prosthetic device to a bone and surrounding tissue of a limb.
- the device includes a sleeve portion 12, a flange portion 14, and a post portion 16.
- the sleeve portion 12 is configured to receive at least a portion of the bone and facilitate fixation with the bone.
- the flange portion 14 extends from the sleeve portion 12 and is configured to abut the bone and surrounding tissue such as various soft tissue (e.g., the skin, subcutaneous tissue, deep tissue, muscles, tendons, and/or fascia) of the limb, while the post portion 16 extends from the flange portion and is configured to be coupled to the prosthetic device 42 (see FIGS. 6-7).
- the device 10 is adaptable to a variety of bones, such as the phalanx, metacarpals, humerus, metatarsals, tarsals, tibia, and femur that are configured to receive various prosthetic devices, such as a digit, foot, or hand and may be various sizes and configurations for accommodating various sized patients.
- the sleeve portion 12 may have a generally cylindrical shape or as shown in FIGS. 2 and 3, the sleeve portion may be slightly tapered between its ends.
- the sleeve portion 12 may have a slightly smaller diameter opening than at its opposite end adjacent to the flange portion 14.
- FIG. 3 shows that the sleeve portion may have various non- circular or irregular configurations, which may be customized for a particular patient and/or bone.
- FIG. 4 illustrates that the sleeve portion 12 has an opening 18 extending between its ends that defines a thin wall 20.
- the end of the bone is configured to be at least partially received within the opening 18 such that the thin wall 20 provides an interface between both its inner surface 24 and the bone and between its outer surface 26 and the surrounding skin, tissue, muscles, tendons, and/or fascia.
- the thin wall 20 may prevent the migration of bacteria from the outer surface of the thin wall towards the bone.
- the sleeve portion 12 may provide sufficient strength and stiffness for load bearing, and the length and stiffness of the sleeve portion may be adjusted for different sized patients and for the amount of fixation desired.
- the sleeve portion 12 may have a textured, coated, and/or porous surface(s) to facilitate bone fixation.
- FIGS. 1, 2, and 4 illustrate that a portion of the outer surface 26 may be a textured/coated/porous surface 22 for facilitating long term fixation between the skin and subcutaneous tissue with the sleeve portion 12.
- FIG. 4 shows that the inner surface 24 of the thin wall 20 may also be textured/coated/porous.
- the textured surface could be rough, raised, or other uneven surface.
- various synthetic or biological coatings or surface treatments may be used to encourage tissue ingrowth into the inner 24 and outer 26 surfaces, such as that disclosed in U.S. Patent No.
- the inner 24 and outer 26 surfaces could employ any one of the following coatings that are useful for their osteoinductive or osteoconductive ability: demineralized bone matrix (DBM), bone morphogenetic proteins (BMPs), transforming growth factors (TGFs), fibroblast growth factors (FGFs), insulin- like growth factors (IGFs), platelet-derived growth factors (PDGFs), epidermal growth factors (EGFs), vascular endothelial growth factors (VEGFs), vascular permeability factors (VPFs), cell adhesion molecules (CAMs), calcium aluminate, hydroxyapatite, coralline hydroxyapatite, alumina, zirconia, aluminum silicates, calcium phosphate, tricalcium phosphate, calcium sulfate, polypropylene fumarate, bioactive glass, porous titanium, porous nickel-titanium alloy, porous tantalum, sintered cobalt-chrome beads, ceramic
- DBM demineralized bone matrix
- BMPs bone morphogenetic proteins
- the coatings may include any medicament useful in facilitating the healing and regenerative process such as, for example, antivirals, antibacterials, antiinflammatories, immunosuppressants, analgesics, anticoagulants, and wound healing promotion agents.
- a bioactive coating may be employed where a patient's cells or stem cells are seeded onto the surface and cultured before implantation to provide a living interface.
- the outer surface 26 is shown as being textured/coated/porous, it is understood that various portions, or the entire outer surface, may be textured/coated/porous.
- the entire inner surface 24 is shown as being textured/coated/porous, only a portion of the inner surface may be textured/coated/porous depending on the amount of fixation desired.
- the sleeve portion 12 may also include one or more holes configured to receive and guide one or more fasteners 28 into the bone for ensuring initial stability with the bone.
- FIGS. 1, 2, and 4 illustrate that the sleeve portion 12 may be configured to receive a plurality of fasteners 28.
- FIG. 1 shows that the sleeve portion 12 includes a pair of fasteners 28, while FIG. 2 shows that the sleeve portion may include four fasteners, although any number of fasteners could be used in order to achieve a particular amount of fixation.
- Each fastener 28 may include a respective head 30 that is configured to engage the sleeve portion 12 and lock in place, such as using a Morse taper or thin thread.
- fasteners 28 may be employed, such as fasteners having a slotted, cruciform, hexagonal, or star head 30 configuration.
- the fasteners may be configured to extend through the bone and out of the opposite side of the sleeve portion as shown in FIGS. 1 and 2, or the fasteners may be configured to extend into and engage a central canal of the bone.
- the fasteners 28 may extend through an upper portion of the sleeve portion 12 as shown in FIGS. 1 and 2 so as to be spaced away from the skin ingrowth surfaces to minimize the likelihood of bacterial infection in the bone.
- the location and/or number of fasteners 28 may be modified for a particular patient or amount of fixation desired.
- FIG. 8 shows that the sleeve portion 12 may include a rod member 58 extending from the flange portion 14.
- the rod member 58 may extend at least partially along the length of the sleeve portion 12 and be configured to engage the end of a bone 59.
- the rod member 58 may be capable of being inserted within the medullary canal of the bone for additional long-term fixation.
- the rod 58 may be various lengths, including extending partially along the length of the sleeve portion 12 or beyond the length of the sleeve portion as shown in FIG. 8.
- the inner and/or outer surfaces of the rod member 58 may be textured, coated, and/or porous for facilitating bone fixation.
- the size and configuration of the rod member 58 may be modified for a particular bone and/or patient.
- the flange portion 14 may extend radially outward from the sleeve portion 12 and post portion 16, as depicted in FIGS. 1-7.
- the flange portion 14 may be configured to abut the bone and surrounding tissue (e.g., skin, subcutaneous tissue, deep tissue, muscles, tendons, and/or fascia).
- the flange portion 14 may be configured to cup the end of the limb for not only protecting the skin, tissue, muscles, tendons, and/or fascia, but also facilitating fixation with the skin, tissue, muscles, tendons, and/or fascia.
- the outer edge 32 may be flat as shown in FIGS. 1 and 5, or the flange 14 may be recessed such that the outer edge is curved so as to extend slightly upwards as shown in FIGS.
- the curved outer edge 32 may be configured to extend around the surrounding skin, tissue, muscles, tendons, and/or fascia.
- a portion of the inner surface 34 of the flange portion 14 may be textured/coated/porous surface for facilitating long term fixation with the skin and subcutaneous tissue. As described above, various coatings or surface treatments may be used to encourage tissue ingrowth, which may be provided on the inner surface 34 of the flange portion 14.
- FIG. 1 shows that the flange portion 14 may include holes 35 for receiving suture that may be used to secure the subcutaneous tissue and skin thereto.
- the flange portion 14 may include a plurality of arched hooks 36 for anchoring the deep soft tissue with suture, as well as a plurality of inner holes 38 for anchoring the subcutaneous tissue and outer holes 40 for anchoring the skin.
- suture may be looped around the hooks 36 or through the holes 38, 40 and through the skin and/or tissue to anchor the skin and/or tissue to the flange portion 14.
- the hooks 36 and holes 38, 40 may be arranged about the circumference of the flange portion 14 or in any other desired configuration to fixate the skin and subcutaneous tissue to the flange portion.
- the post portion 18 extends from the flange portion 14 opposite the sleeve portion 12 and is configured to mate with and provide a modular fixation to a prosthetic device 42.
- the post portion 16 is of a sufficient length to facilitate alignment and mechanical engagement with a stem 44 of the prosthetic device 42.
- the post portion 16 may be generally cylindrical and include an opening 46 for coupling with the stem 44 of the prosthetic device 42 (shown in FIGS. 6-7).
- the opening 46 is tapered and capable of receiving a correspondingly tapered end 48 of the stem 44.
- the post portion 16 may include a threaded portion 50 configured to engage threads 52 defined within an opening 54 of a self-locking nut 56.
- the self-locking nut 56 is configured to slide over the stem 44 and thread onto the threaded portion 50 of the post portion 16 such that the tapered end 48 is positively secured within the tapered opening 46.
- the opening 46 may be different sizes and configurations for mating with a variety of stems 44.
- the opening may be circular in cross section and configured to receive a cylindrical stem and secured therein with a fastener.
- the opening of the post portion 16 could include threads configured to engage a threaded stem.
- the size and configuration of the post portion 18 may be modified for particular bones and/or patients.
- the device 10 may comprise a variety of biocompatible metallic, composite, and/or polymeric materials that may include, for example, stainless steel, titanium, hydroxyapatite, fiber-reinforced polymer composites (e.g., carbon fiber composites), and combinations of such materials.
- biocompatible metallic, composite, and/or polymeric materials may include, for example, stainless steel, titanium, hydroxyapatite, fiber-reinforced polymer composites (e.g., carbon fiber composites), and combinations of such materials.
- the device 10 may be customized for a particular patient by imaging the patient's limb in order to create a computer model of the limb.
- a computed tomography (CT) scan of the patient's limb could be made and used to create a computer model of the limb such as with computer-aided design or other software known to those of ordinary skill in the art.
- a three-dimensional model of the limb including the patient's bone and skin may be created, and the model may be used in conjunction with an additive manufacturing process, such as an energy-beam additive manufacturing process, that is capable of being programmed to automatically form the device 10.
- an energy beam laser or electron beam
- an electron beam melting (EBM) process may be used to selectively melt metal powder one layer at the time.
- a three-dimensional computer model may be "sliced" into thin cross sections, and the beam may be controlled to follow the contours and fill in the areas to be solid.
- EBM electron beam melting
- the following list of references describes various additive manufacturing techniques that may be used to form the device 10 and are hereby incorporated by reference in their entirety herein: Cansizoglu O., Harrysson O. L. A., Cormier D. R., West II H. A., Mahale T., 2008, Properties of Ti-6A1-4V Non-stochastic Lattice Structures Fabricated Via Electron Beam Melting, Materials Science & Engineering A, 492, pp. 468-474; Schmitt, Stephen,
- the device 10 may be integrally formed with one step using an additive manufacturing process, which includes forming various textured surfaces for promoting tissue and bone ingrowth. Various machining or polishing steps may be used in order to finish the device, such as computer numerical control machining.
- the surgeon is able to implant the device.
- a surgeon may be able to decide where to cut the bone, the orientation and placement of the device 10 on the bone, and customize the device for a particular bone.
- the surgical procedure may vary depending on the particular patient and the surgeon's preferences.
- the procedure may generally include making an incision in the limb in order to expose the bone and cutting the end of the bone in order to size the bone to be positioned within the sleeve portion 12. For example, the tip of the bone or any irregularities may be removed in order to position the bone within the sleeve portion 12.
- the surrounding skin and tissue may then be reflected in order to expose the bone, and any minor modifications to the bone and skin may be made to ensure a proper fit before securing the device 10 to the bone.
- the bone may then be positioned within the sleeve portion 12, and the end of the bone and/or surrounding soft tissue could abut the flange portion 14 or be positioned proximate thereto.
- FIG. 9 shows a limb 60 having the tissue surrounding the bone displaced and the sleeve portion 12 positioned on the end of the bone. Once the bone is positioned within the sleeve portion 12, holes may be drilled for receiving the fasteners 28.
- the drill may be guided with a drill guide, or the holes defined in the sleeve portion 12 may be used as a drill guide.
- the fasteners 28 are then inserted through the holes to secure the device 10 to the bone.
- the subcutaneous tissue may be replaced or removed in order to properly position the tissue around the sleeve portion 12.
- the skin, tissue, muscles, tendons, and/or fascia may be reattached with sutures around the device 10 such that the flange portion abuts the surrounding skin, tissue, muscles, tendons, and/or fascia as shown in FIG. 10.
- Images may be made of the limb following surgery using techniques such as radiographs, CT scans, dual-energy x-ray absorptiometry (DEXA) scanning, and other suitable imaging methods in order to confirm the position of the device 10.
- the surgeon may monitor the progress of the fixation of the device by taking bone biopsies or further images.
- a prosthetic device 42 may be attached to the post portion 16, such as shown in FIG. 10.
- the device 10 is configured to reduce the incidence of infection by providing a barrier between the bone and the surrounding skin and subcutaneous tissue, and the flange portion 14 is configured to protect the soft tissue at the extremity of the limb.
- the combination of the fasteners and porous/textured/coated surfaces may facilitate integration of the device in the bone so as to provide adequate long-term fixation.
- the device is adaptable to a variety of limbs, as the device may be customized for each patient and automatically formed using an additive manufacturing process, which may result in more effective long-term fixation.
- the sleeve portion 12, flange portion 14, and post portion 16 may be integrally formed from a single piece of material thereby decreasing the likelihood of breakage and the cost of fabricating the implant.
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Prostheses (AREA)
Abstract
Various embodiments of the present invention provide, for example, a transcutaneous osseointegrated device (10) for fixating a prosthetic device to a bone and surrounding tissue of a limb. The device includes a sleeve portion (12) configured to receive at least a portion of the bone and be fixated to the bone and a flange portion (14) adjacent to the sleeve portion and configured to abut the bone and surrounding tissue. The device further includes a post portion (16) extending from the flange portion that is configured to be coupled to the prosthetic device.
Description
TRANSCUTANEOUS OSSEOINTEGRATED DEVICE FOR PROSTHESES
FIELD OF INVENTION
Various embodiments of the present invention relate to devices and methods for securing a prosthetic device to an anatomical structure and, in particular, to a transcutaneous osseointegrated device configured to be fixated to an anatomical structure and coupled to a prosthetic device.
BACKGROUND OF THE INVENTION
External prosthesis have been used to improve mobility and function of humans and animals with missing extremities. While external prosthesis may be used, they have several limitations that complicate their use and limit their benefits. For example, external prosthesis may only be fitted on limbs with relatively long stumps, place pressure on soft tissue, have a suboptimal transfer of forces during locomotion resulting from forces traveling through soft tissue, and have relatively high wear rates.
The utility of limb prostheses, particularly weight-bearing prosthetic devices (such as artificial legs and/or feet), is often dramatically increased if the prosthetic device is anchored to and/or embedded in a bone structure of a residual limb. However, fixation of limb prostheses to a bony structure typically requires the use of a transcutaneous adapter extending from the bone to an externally-located prosthetic device via an opening in the skin of the residual limb. Such openings may allow infection to develop in the residual limb. Furthermore, the onset of infection in such conventional systems may result in the need for the complete removal and/or replacement of the transcutaneous member. Because such systems often include a transcutaneous adapter that is integrated with a bone-fixation portion (such as an implantable stem and/or bone plate attached to the bone via screws), inpatient surgical procedures may be required to replace the entire system in an attempt to treat the infection.
Furthermore, many conventional prosthetic systems provide a single, large- diameter, transcutaneous adapter that is tasked with supporting the majority of the force exerted on the suspension system as the user ambulates. Thus, the single transcutaneous adapter may, in some cases, be prone to failure and/or premature wear, particularly at points where the bone fixation portion is not adequately integrated with the bone.
Thus, there remains a need in the art for an improved transcutaneous device. In particular, there is a need for a transcutaneous device that is configured to reduce the incidence of infection. Moreover, there is a need for a transcutaneous device that may be sufficiently integrated in the bone of the limb so as to provide adequate fixation. Furthermore, there is a need for a transcutaneous device that is adaptable to a variety of limbs.
SUMMARY OF THE INVENTION The above and other needs may be met by embodiments of the present invention which, in one embodiment, provides a transcutaneous osseointegrated device for fixation of prosthetic devices. The device is configured to reduce the incidence of infection and promote long-term fixation with the limb. The device may be used for receiving various prostheses, such as a foot or hand and may be various sizes and configurations for accommodating various sized patients. According to one embodiment, the device includes a sleeve portion configured to receive at least a portion of a bone and be fixated to the bone and a flange portion adjacent to the sleeve portion and configured to abut the end of the limb (e.g., the bone, surrounding skin, tissue, muscles, tendons, and/or fascia). The flange portion has a first side facing the sleeve portion and an opposing second side. The device further includes a post portion extending from the second surface and configured to be coupled with a prosthetic device. The sleeve portion may include an opening and a thin wall such that the bone is configured to be received within the opening, and such that the thin wall provides an interface between both its interior surface and the bone and between its outer surface and the surrounding tissue. The flange portion may extend radially outward from the sleeve portion and the first side of the flange portion may be configured to cup the end of the bone and surrounding tissue.
According to various aspects of the device, the inner surface of the sleeve may be textured, coated, and/or porous to facilitate bone fixation. The outer surface of the sleeve may also be textured, coated, and/or porous to promote tissue in-growth and/or on-growth.
Similarly, at least a portion of the first side of the flange may be textured, coated, and/or porous to promote in-growth and/or on-growth with the tissue. Moreover, the sleeve portion may include a plurality of holes for receiving respective fasteners. The heads of the fasteners may be configured to engage the sleeve portion and lock in place using a Morse taper or thin thread. Alternatively, the fasteners may be configured to extend through the sleeve portion and into the central canal of the bone, such as for larger bones.
Furthermore, the post portion may be configured for threaded engagement with the prosthetic device. For example, the post portion may include a threaded surface, and the device may further include a threaded nut having a hole configured to receive a stem of the prosthetic device and engage the threaded surface of the post portion. The post portion may also include a tapered hole that is configured to mate with a correspondingly tapered end of the stem. The device may be integrally defined from a single piece of material, such as a biocompatible metal material.
An additional embodiment provides a method for manufacturing a transcutaneous osseointegrated device for fixation of a prosthetic device to a bone and surrounding tissue of a limb. The method includes integrally forming a transcutaneous osseointegrated device comprising a sleeve portion, a flange portion, and a post portion using an additive manufacturing process (e.g., an energy-beam additive manufacturing process). In addition, the method may include imaging the limb and creating a computer model of the limb based on the imaging, wherein integrally forming comprises automatically forming the transcutaneous osseointegrated device in accordance with the computer model. Moreover, an embodiment of the present invention provides a method for fixating a prosthetic device to a bone and surrounding tissue of a limb with a transcutaneous osseointegrated device. The method includes providing a transcutaneous osseointegrated device comprising a sleeve portion, a flange portion, and a post portion, positioning at least a portion of the bone within the sleeve portion such that the flange portion abuts the bone and surrounding tissue, and coupling the post portion to the prosthetic device.
BRIEF DESCRIPTION OF THE DRAWINGS Various embodiments of the invention will be better understood by reference to the
Detailed Description of Various Embodiments of the Invention when taken together with the attached drawings, wherein:
FIG. 1 is a perspective view of a transcutaneous osseointegrated device according to one embodiment of the present invention;
FIG. 2 is a perspective view of a transcutaneous osseointegrated device according to another embodiment of the present invention; FIG. 3 is an end view of the transcutaneous osseointegrated device shown in FIG.
2;
FIG. 4 is cross-sectional view of the transcutaneous osseointegrated device shown in FIG. 2;
FIG. 5 is a partial cross-sectional view of a transcutaneous osseointegrated device with a stem coupled thereto according to one embodiment of the present invention;
FIG. 6 is a partial perspective view of a transcutaneous osseointegrated device coupled to a prosthetic device according to one embodiment of the present invention;
FIG. 7 is an exploded perspective view of the transcutaneous osseointegrated device and prosthetic device shown in FIG. 6; FIG. 8 is a cross-sectional view of a transcutaneous osseointegrated device according to an additional embodiment of the present invention;
FIG. 9 is a perspective view of a transcutaneous osseointegrated device installed within a tibia of a feline according to an additional embodiment of the present invention; and FIG. 10 is a perspective view of the transcutaneous osseointegrated device of FIG.
9 having a prosthetic device coupled thereto.
DETAILED DESCRIPTION OF VARIOUS EMBODIMENTS OF THE INVENTION
Various embodiments of the present invention now will be described more fully hereinafter with reference to the accompanying drawings, in which some, but not all embodiments of the invention are shown. Indeed, various embodiments of the invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will satisfy applicable legal requirements. Like numbers refer to like elements throughout. The singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.
As shown generally in FIG. 1, embodiments of the present invention generally provide a transcutaneous osseointegrated device 10 for fixation of a prosthetic device to a bone and surrounding tissue of a limb. Generally, the device includes a sleeve portion 12,
a flange portion 14, and a post portion 16. The sleeve portion 12 is configured to receive at least a portion of the bone and facilitate fixation with the bone. The flange portion 14 extends from the sleeve portion 12 and is configured to abut the bone and surrounding tissue such as various soft tissue (e.g., the skin, subcutaneous tissue, deep tissue, muscles, tendons, and/or fascia) of the limb, while the post portion 16 extends from the flange portion and is configured to be coupled to the prosthetic device 42 (see FIGS. 6-7). The device 10 is adaptable to a variety of bones, such as the phalanx, metacarpals, humerus, metatarsals, tarsals, tibia, and femur that are configured to receive various prosthetic devices, such as a digit, foot, or hand and may be various sizes and configurations for accommodating various sized patients.
Referring again to FIG. 1, the sleeve portion 12 may have a generally cylindrical shape or as shown in FIGS. 2 and 3, the sleeve portion may be slightly tapered between its ends. In particular, the sleeve portion 12 may have a slightly smaller diameter opening than at its opposite end adjacent to the flange portion 14. Although the sleeve portion 12 may have a circular opening, FIG. 3 shows that the sleeve portion may have various non- circular or irregular configurations, which may be customized for a particular patient and/or bone. FIG. 4 illustrates that the sleeve portion 12 has an opening 18 extending between its ends that defines a thin wall 20. The end of the bone is configured to be at least partially received within the opening 18 such that the thin wall 20 provides an interface between both its inner surface 24 and the bone and between its outer surface 26 and the surrounding skin, tissue, muscles, tendons, and/or fascia. Thus, the thin wall 20 may prevent the migration of bacteria from the outer surface of the thin wall towards the bone. The sleeve portion 12 may provide sufficient strength and stiffness for load bearing, and the length and stiffness of the sleeve portion may be adjusted for different sized patients and for the amount of fixation desired.
The sleeve portion 12 may have a textured, coated, and/or porous surface(s) to facilitate bone fixation. For example, FIGS. 1, 2, and 4 illustrate that a portion of the outer surface 26 may be a textured/coated/porous surface 22 for facilitating long term fixation between the skin and subcutaneous tissue with the sleeve portion 12. Moreover, FIG. 4 shows that the inner surface 24 of the thin wall 20 may also be textured/coated/porous. For instance, the textured surface could be rough, raised, or other uneven surface. According to one embodiment, various synthetic or biological coatings or surface treatments may be used to encourage tissue ingrowth into the inner 24 and outer 26 surfaces, such as that disclosed in U.S. Patent No. 7,014,661, which is hereby incorporated
by reference in its entirety herein. Moreover, the inner 24 and outer 26 surfaces could employ any one of the following coatings that are useful for their osteoinductive or osteoconductive ability: demineralized bone matrix (DBM), bone morphogenetic proteins (BMPs), transforming growth factors (TGFs), fibroblast growth factors (FGFs), insulin- like growth factors (IGFs), platelet-derived growth factors (PDGFs), epidermal growth factors (EGFs), vascular endothelial growth factors (VEGFs), vascular permeability factors (VPFs), cell adhesion molecules (CAMs), calcium aluminate, hydroxyapatite, coralline hydroxyapatite, alumina, zirconia, aluminum silicates, calcium phosphate, tricalcium phosphate, calcium sulfate, polypropylene fumarate, bioactive glass, porous titanium, porous nickel-titanium alloy, porous tantalum, sintered cobalt-chrome beads, ceramics, collagen, autologous bone, allogenic bone, xenogenic bone, coralline, and derivates or combinations thereof, or other biologically produced composite materials containing calcium or hydroxyapatite structural elements. In addition, the coatings may include any medicament useful in facilitating the healing and regenerative process such as, for example, antivirals, antibacterials, antiinflammatories, immunosuppressants, analgesics, anticoagulants, and wound healing promotion agents. Alternatively, a bioactive coating may be employed where a patient's cells or stem cells are seeded onto the surface and cultured before implantation to provide a living interface. Although only a lower portion of the outer surface 26 is shown as being textured/coated/porous, it is understood that various portions, or the entire outer surface, may be textured/coated/porous. Similarly, although the entire inner surface 24 is shown as being textured/coated/porous, only a portion of the inner surface may be textured/coated/porous depending on the amount of fixation desired.
The sleeve portion 12 may also include one or more holes configured to receive and guide one or more fasteners 28 into the bone for ensuring initial stability with the bone. In particular, FIGS. 1, 2, and 4 illustrate that the sleeve portion 12 may be configured to receive a plurality of fasteners 28. FIG. 1 shows that the sleeve portion 12 includes a pair of fasteners 28, while FIG. 2 shows that the sleeve portion may include four fasteners, although any number of fasteners could be used in order to achieve a particular amount of fixation. Each fastener 28 may include a respective head 30 that is configured to engage the sleeve portion 12 and lock in place, such as using a Morse taper or thin thread. Various types of fasteners 28 may be employed, such as fasteners having a slotted, cruciform, hexagonal, or star head 30 configuration. Depending on the size of the bone and/or fasteners 28, the fasteners may be configured to extend through the bone and
out of the opposite side of the sleeve portion as shown in FIGS. 1 and 2, or the fasteners may be configured to extend into and engage a central canal of the bone. The fasteners 28 may extend through an upper portion of the sleeve portion 12 as shown in FIGS. 1 and 2 so as to be spaced away from the skin ingrowth surfaces to minimize the likelihood of bacterial infection in the bone. However, the location and/or number of fasteners 28 may be modified for a particular patient or amount of fixation desired.
Furthermore, FIG. 8 shows that the sleeve portion 12 may include a rod member 58 extending from the flange portion 14. The rod member 58 may extend at least partially along the length of the sleeve portion 12 and be configured to engage the end of a bone 59. For instance, the rod member 58 may be capable of being inserted within the medullary canal of the bone for additional long-term fixation. The rod 58 may be various lengths, including extending partially along the length of the sleeve portion 12 or beyond the length of the sleeve portion as shown in FIG. 8. Moreover, the inner and/or outer surfaces of the rod member 58 may be textured, coated, and/or porous for facilitating bone fixation. In addition, it is understood that the size and configuration of the rod member 58 may be modified for a particular bone and/or patient.
The flange portion 14 may extend radially outward from the sleeve portion 12 and post portion 16, as depicted in FIGS. 1-7. The flange portion 14 may be configured to abut the bone and surrounding tissue (e.g., skin, subcutaneous tissue, deep tissue, muscles, tendons, and/or fascia). Thus, the flange portion 14 may be configured to cup the end of the limb for not only protecting the skin, tissue, muscles, tendons, and/or fascia, but also facilitating fixation with the skin, tissue, muscles, tendons, and/or fascia. The outer edge 32 may be flat as shown in FIGS. 1 and 5, or the flange 14 may be recessed such that the outer edge is curved so as to extend slightly upwards as shown in FIGS. 2 and 4. The curved outer edge 32 may be configured to extend around the surrounding skin, tissue, muscles, tendons, and/or fascia. A portion of the inner surface 34 of the flange portion 14 may be textured/coated/porous surface for facilitating long term fixation with the skin and subcutaneous tissue. As described above, various coatings or surface treatments may be used to encourage tissue ingrowth, which may be provided on the inner surface 34 of the flange portion 14.
FIG. 1 shows that the flange portion 14 may include holes 35 for receiving suture that may be used to secure the subcutaneous tissue and skin thereto. In addition, the flange portion 14 may include a plurality of arched hooks 36 for anchoring the deep soft tissue with suture, as well as a plurality of inner holes 38 for anchoring the subcutaneous
tissue and outer holes 40 for anchoring the skin. Thus, suture may be looped around the hooks 36 or through the holes 38, 40 and through the skin and/or tissue to anchor the skin and/or tissue to the flange portion 14. The hooks 36 and holes 38, 40 may be arranged about the circumference of the flange portion 14 or in any other desired configuration to fixate the skin and subcutaneous tissue to the flange portion.
The post portion 18 extends from the flange portion 14 opposite the sleeve portion 12 and is configured to mate with and provide a modular fixation to a prosthetic device 42. The post portion 16 is of a sufficient length to facilitate alignment and mechanical engagement with a stem 44 of the prosthetic device 42. For example, the post portion 16 may be generally cylindrical and include an opening 46 for coupling with the stem 44 of the prosthetic device 42 (shown in FIGS. 6-7). According to one embodiment, the opening 46 is tapered and capable of receiving a correspondingly tapered end 48 of the stem 44. Furthermore, the post portion 16 may include a threaded portion 50 configured to engage threads 52 defined within an opening 54 of a self-locking nut 56. More specifically, the self-locking nut 56 is configured to slide over the stem 44 and thread onto the threaded portion 50 of the post portion 16 such that the tapered end 48 is positively secured within the tapered opening 46. It is understood that the opening 46 may be different sizes and configurations for mating with a variety of stems 44. For example, the opening may be circular in cross section and configured to receive a cylindrical stem and secured therein with a fastener. Or, the opening of the post portion 16 could include threads configured to engage a threaded stem. Furthermore, the size and configuration of the post portion 18 may be modified for particular bones and/or patients.
The device 10 may comprise a variety of biocompatible metallic, composite, and/or polymeric materials that may include, for example, stainless steel, titanium, hydroxyapatite, fiber-reinforced polymer composites (e.g., carbon fiber composites), and combinations of such materials.
According one embodiment, the device 10 may be customized for a particular patient by imaging the patient's limb in order to create a computer model of the limb. For example, a computed tomography (CT) scan of the patient's limb could be made and used to create a computer model of the limb such as with computer-aided design or other software known to those of ordinary skill in the art. A three-dimensional model of the limb including the patient's bone and skin may be created, and the model may be used in conjunction with an additive manufacturing process, such as an energy-beam additive manufacturing process, that is capable of being programmed to automatically form the
device 10. According to one embodiment, an energy beam (laser or electron beam) may be used. In one aspect, an electron beam melting (EBM) process may be used to selectively melt metal powder one layer at the time. A three-dimensional computer model may be "sliced" into thin cross sections, and the beam may be controlled to follow the contours and fill in the areas to be solid. According to exemplary embodiments, the following list of references describes various additive manufacturing techniques that may be used to form the device 10 and are hereby incorporated by reference in their entirety herein: Cansizoglu O., Harrysson O. L. A., Cormier D. R., West II H. A., Mahale T., 2008, Properties of Ti-6A1-4V Non-stochastic Lattice Structures Fabricated Via Electron Beam Melting, Materials Science & Engineering A, 492, pp. 468-474; Schmitt, Stephen,
Harrysson, Ola L. A., 2008, Digital Fabrication of Dental Restoration: The Final Step in the Digital Process, Dentistry Today, In Press; Cormier, Denis R., Harrysson, Ola L. A., Mahale, Tushar, West, Harvey, 2007, Freeform Fabrication of Titanium Aluminide Via Electron Beam Melting, Research Letters in Material Science, Volume 2007, Article ID 34737, 4 pages; O. Cansizoglu, O. L. A. Harrysson, H. A. West II, D. R. Cormier, T.
Mahale, 2008, Applications of Structural Optimization in Direct Metal Fabrication, Rapid Prototyping Journal, Vol. 14, No. 2, pp. 114-122; Marcellin-Little, Denis, Harrysson, Ola L. A., Cansizoglu, Omer, 2008, In Vitro Evaluation of a Custom Cutting Jig and Custom Plate for Canine Tibial Plateau Leveling. American Journal of Veterinary Research, Vol. 69, No. 7, July 2008 pp. 961-966; Harrysson, Ola L. A., Omer Cansizoglu, Denis J. Marcellin-Little, Denis R. Cormier, and Harvey A. West II. 2008. "Direct Metal Fabrication of Titanium Implants with Tailored Materials and Mechanical Properties Using Electron Beam Melting Technology," Materials Science & Engineering C, Vol. 28, No 3, pp. 366-373; and Harrysson, O. L. A., and Denis R. Cormier. 2006. "Direct Fabrication of Custom Orthopedic Implants using Electron Beam Melting Technology," Chapter 9, in Advanced Manufacturing Technology for Medical Applications, Eds. I. Gibson, John Wiley & Sons, Ltd., p 193-208. Moreover, the device 10 may be integrally formed with one step using an additive manufacturing process, which includes forming various textured surfaces for promoting tissue and bone ingrowth. Various machining or polishing steps may be used in order to finish the device, such as computer numerical control machining.
Once the model is complete and the device 10 designed for a limb, the surgeon is able to implant the device. Using the model, a surgeon may be able to decide where to cut the bone, the orientation and placement of the device 10 on the bone, and customize the
device for a particular bone. The surgical procedure may vary depending on the particular patient and the surgeon's preferences. The procedure may generally include making an incision in the limb in order to expose the bone and cutting the end of the bone in order to size the bone to be positioned within the sleeve portion 12. For example, the tip of the bone or any irregularities may be removed in order to position the bone within the sleeve portion 12. The surrounding skin and tissue may then be reflected in order to expose the bone, and any minor modifications to the bone and skin may be made to ensure a proper fit before securing the device 10 to the bone. The bone may then be positioned within the sleeve portion 12, and the end of the bone and/or surrounding soft tissue could abut the flange portion 14 or be positioned proximate thereto. For instance, FIG. 9 shows a limb 60 having the tissue surrounding the bone displaced and the sleeve portion 12 positioned on the end of the bone. Once the bone is positioned within the sleeve portion 12, holes may be drilled for receiving the fasteners 28. The drill may be guided with a drill guide, or the holes defined in the sleeve portion 12 may be used as a drill guide. The fasteners 28 are then inserted through the holes to secure the device 10 to the bone. The subcutaneous tissue may be replaced or removed in order to properly position the tissue around the sleeve portion 12. The skin, tissue, muscles, tendons, and/or fascia may be reattached with sutures around the device 10 such that the flange portion abuts the surrounding skin, tissue, muscles, tendons, and/or fascia as shown in FIG. 10. Images may be made of the limb following surgery using techniques such as radiographs, CT scans, dual-energy x-ray absorptiometry (DEXA) scanning, and other suitable imaging methods in order to confirm the position of the device 10. The surgeon may monitor the progress of the fixation of the device by taking bone biopsies or further images. After allowing for adequate recovery time, a prosthetic device 42 may be attached to the post portion 16, such as shown in FIG. 10.
Therefore, embodiments of the present invention may provide several advantages. For example, the device 10 is configured to reduce the incidence of infection by providing a barrier between the bone and the surrounding skin and subcutaneous tissue, and the flange portion 14 is configured to protect the soft tissue at the extremity of the limb. Moreover, the combination of the fasteners and porous/textured/coated surfaces may facilitate integration of the device in the bone so as to provide adequate long-term fixation. Furthermore, the device is adaptable to a variety of limbs, as the device may be customized for each patient and automatically formed using an additive manufacturing process, which may result in more effective long-term fixation. In addition, the sleeve
portion 12, flange portion 14, and post portion 16 may be integrally formed from a single piece of material thereby decreasing the likelihood of breakage and the cost of fabricating the implant.
Many modifications and other various embodiments of the invention set forth herein will come to mind to one skilled in the art to which this invention pertains having the benefit of the teachings presented in the foregoing descriptions and the associated drawings. Therefore, it is to be understood that the various embodiments of the invention are not to be limited to the specific embodiments disclosed and that modifications and other embodiments are intended to be included within the scope of the appended claims. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not for purposes of limitation.
Claims
1. A transcutaneous osseointegrated device for fixation of a prosthetic device to a bone and surrounding tissue of a limb, the device comprising: a sleeve portion configured to receive at least a portion of the bone and be fixated to the bone; a flange portion adjacent to the sleeve portion and configured to abut the bone and surrounding tissue, the flange portion have a first side facing the sleeve portion and an opposing second side; and a post portion extending from the second side of the flange portion and configured to be coupled to the prosthetic device.
2. The device of Claim 1, wherein the sleeve portion comprises an opening and a thin wall having an inner and outer surface such that the bone is configured to be received within the opening and such that the thin wall provides an interface between both its inner surface and the bone and between its outer surface and the surrounding tissue.
3. The device of Claim 2, wherein at least a portion of the inner surface of the sleeve portion is textured, coated, and/or porous to facilitate bone fixation.
4. The device of Claim 2, wherein at least a portion of the outer surface of the sleeve portion is textured, coated, and/or porous to promote tissue in-growth and/or on- growth.
5. The device of Claim 1, wherein at least a portion of the first side of the flange portion is textured, coated, and/or porous to promote in-growth and/or on-growth with the surrounding tissue.
6. The device of Claim 1 , wherein the flange portion extends radially outward from the sleeve portion and the first side of the flange portion is configured to cup the end of the bone and surrounding tissue.
7. The device of Claim 1 , wherein the sleeve portion comprises a plurality of holes for receiving respective fasteners.
8. The device of Claim 7, wherein each fastener comprises a respective head, and wherein each head is configured to engage the sleeve portion and lock in place using a Morse taper or thin thread.
9. The device of Claim 7, wherein the fasteners are configured to extend through the sleeve portion and into a central canal of the bone.
10. The device of Claim 1, wherein the post portion is configured for threaded engagement with the prosthetic device.
11. The device of Claim 1 , wherein the post portion comprises a threaded surface and further comprising a threaded nut comprising a hole configured to receive a stem of the prosthetic device and engage the threaded surface of the post portion.
12. The device of Claim 11 , wherein the post portion comprises a tapered hole that is configured to mate with a correspondingly tapered end of the stem.
13. The device of Claim 1, wherein the sleeve portion, flange portion, and post portion are integrally formed from a single piece of material.
14. A method for manufacturing a transcutaneous osseointegrated device for fixation of a prosthetic device to a bone and surrounding tissue of a limb, the method comprising: integrally forming a transcutaneous osseointegrated device comprising a sleeve portion, a flange portion, and a post portion using an additive manufacturing process.
15. The method of Claim 14, wherein the sleeve portion is configured to receive at least a portion of the bone and be fixated to the bone, wherein the flange portion extends from the sleeve portion and is configured to abut the bone and surrounding tissue, and wherein the post portion extends from the flange portion and is configured to be coupled to the prosthetic device.
16. The method of Claim 14, wherein the additive manufacturing process comprises an energy-beam additive manufacturing process.
17. The method of Claim 14, further comprising imaging the limb and creating a computer model of the limb based on the imaging, wherein integrally forming comprises automatically forming the transcutaneous osseointegrated device in accordance with the computer model.
18. A method for fixating a prosthetic device to a bone and surrounding tissue of a limb with a transcutaneous osseointegrated device, the method comprising: providing a transcutaneous osseointegrated device comprising a sleeve portion, a flange portion, and a post portion; positioning at least a portion of the bone within the sleeve portion such that the flange portion abuts the bone and surrounding tissue; and coupling the post portion to the prosthetic device.
19. The method of Claim 18, further comprising extending a plurality of fasteners through the sleeve portion and into the bone.
20. The method of Claim 18, further comprising threadably attaching the prosthetic device to the post portion.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2970008P | 2008-02-19 | 2008-02-19 | |
US61/029,700 | 2008-02-19 | ||
US8476908P | 2008-07-30 | 2008-07-30 | |
US61/084,769 | 2008-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009105535A1 true WO2009105535A1 (en) | 2009-08-27 |
Family
ID=40478920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/034512 WO2009105535A1 (en) | 2008-02-19 | 2009-02-19 | Transcutaneous osseointegrated device for prostheses |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009105535A1 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITFI20110158A1 (en) * | 2011-07-29 | 2013-01-30 | Erik Cocchetti | SYSTEM OF CALCINABLE COMPONENTS TO REALLIZE THE MEANS OF CONNECTION OF ORTHOPEDIC PROSTHESIS TO BONE TO WHICH THEY ARE INTENDED AND A METHOD FOR ITS REALIZATION. |
WO2013048589A1 (en) | 2011-06-06 | 2013-04-04 | University Of Utah Research Foundation | Percutaneous osseointegrated prosthetic implant system |
US20140195002A1 (en) * | 2011-06-06 | 2014-07-10 | University Of Utah Research Foundation | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
US9308103B1 (en) | 2013-08-20 | 2016-04-12 | David T. Kluger | Osseointegrated mount for prosthetic limb and peripheral nerve interface |
US20160100961A1 (en) * | 2010-02-01 | 2016-04-14 | Biomet Manufacturing, Llc | Transdermal intraosseous device |
EP2967919A4 (en) * | 2013-03-15 | 2016-11-23 | Ohio Willow Wood Co | Additive manufacturing produced prosthetic foot |
US9839535B2 (en) | 2012-07-20 | 2017-12-12 | University Of Utah Research Foundation | Modular prosthetic abutment system |
RU185647U1 (en) * | 2018-06-26 | 2018-12-13 | Общество С Ограниченной Ответственностью "Предприятие "Сенсор" | Device for osseointegration of the implant in the bone of the stump of the lower limb |
US10342554B2 (en) | 2016-06-17 | 2019-07-09 | Socovar, L.P. | Limb sparing in mammals using patient-specific endoprostheses and cutting guides |
ES2736410A1 (en) * | 2019-07-12 | 2019-12-30 | Univ Madrid Complutense | Customized endoprosthesis for long bones of animals |
US10792154B2 (en) | 2016-06-17 | 2020-10-06 | Socovar, L.P. | Limb sparing in mammals using patient-specific endoprostheses and cutting guides |
WO2021071235A1 (en) * | 2019-10-11 | 2021-04-15 | 국립암센터 | Implant for amputated bone having mesh flange for directly connecting prosthesis to skeleton |
IT202000000196A1 (en) * | 2020-01-09 | 2021-07-09 | Adler Ortho S P A | Improved orthopedic implant with diaphyseal and / or metaphyseal filling. |
US11730520B2 (en) | 2017-08-07 | 2023-08-22 | Mt Innovations, Llc. | Orthopaedic fixation assembly, system, and method of use |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19826638A1 (en) * | 1998-06-17 | 1999-12-30 | Eska Implants Gmbh & Co | Adapter for an exoprosthetic standard part |
WO2003084429A2 (en) * | 2002-04-09 | 2003-10-16 | Hugo Alejandro Orta Medina | Prosthesis with a skeletal point of support for upper or lower extremities |
EP1407727A1 (en) * | 2002-10-08 | 2004-04-14 | ESKA Implants GmbH & Co. | Subcutaneous, intra-muscular coupling for a rigid transcutaneous implant |
DE202004014043U1 (en) * | 2004-09-07 | 2004-12-02 | Eska Implants Gmbh & Co. | Subcutaneous, intramuscular bearing for a rigid transcutaneous implant |
EP1529501A1 (en) * | 2003-11-07 | 2005-05-11 | ESKA Implants GmbH & Co. | Subcutaneous, intra-muscular coupling for a rigid transcutaneous implant |
WO2006107292A1 (en) * | 2005-03-30 | 2006-10-12 | Trimanus Medical Limited | Biologic barrier for implants that pass through mucosal or cutaneous tissue |
WO2007013948A2 (en) * | 2005-07-20 | 2007-02-01 | University Of Utah Research Foundation | Antimicrobial containment cap for a bone anchored prosthesis mounting system |
US20070150070A1 (en) * | 2005-12-22 | 2007-06-28 | Workers Accident Medical Corporation | Implant device for osseointegration to endure weight |
-
2009
- 2009-02-19 WO PCT/US2009/034512 patent/WO2009105535A1/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19826638A1 (en) * | 1998-06-17 | 1999-12-30 | Eska Implants Gmbh & Co | Adapter for an exoprosthetic standard part |
WO2003084429A2 (en) * | 2002-04-09 | 2003-10-16 | Hugo Alejandro Orta Medina | Prosthesis with a skeletal point of support for upper or lower extremities |
EP1407727A1 (en) * | 2002-10-08 | 2004-04-14 | ESKA Implants GmbH & Co. | Subcutaneous, intra-muscular coupling for a rigid transcutaneous implant |
EP1529501A1 (en) * | 2003-11-07 | 2005-05-11 | ESKA Implants GmbH & Co. | Subcutaneous, intra-muscular coupling for a rigid transcutaneous implant |
DE202004014043U1 (en) * | 2004-09-07 | 2004-12-02 | Eska Implants Gmbh & Co. | Subcutaneous, intramuscular bearing for a rigid transcutaneous implant |
WO2006107292A1 (en) * | 2005-03-30 | 2006-10-12 | Trimanus Medical Limited | Biologic barrier for implants that pass through mucosal or cutaneous tissue |
WO2007013948A2 (en) * | 2005-07-20 | 2007-02-01 | University Of Utah Research Foundation | Antimicrobial containment cap for a bone anchored prosthesis mounting system |
US20070150070A1 (en) * | 2005-12-22 | 2007-06-28 | Workers Accident Medical Corporation | Implant device for osseointegration to endure weight |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160100961A1 (en) * | 2010-02-01 | 2016-04-14 | Biomet Manufacturing, Llc | Transdermal intraosseous device |
US20190091042A1 (en) * | 2010-02-01 | 2019-03-28 | Biomet Manufacturing, Llc | Transdermal intraosseous device |
US10166125B2 (en) * | 2010-02-01 | 2019-01-01 | Biomet Manufacturing, Llc | Transdermal intraosseous device |
US9668889B2 (en) | 2011-06-06 | 2017-06-06 | University Of Utah Research Foundation | Percutaneous osseointegrated prosthetic implant system |
US9433505B2 (en) | 2011-06-06 | 2016-09-06 | University Of Utah Research Foundation | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
JP2014522282A (en) * | 2011-06-06 | 2014-09-04 | ユニヴァーシティ オブ ユタ リサーチ ファンデーション | Percutaneous osteosynthesis prosthetic implant system |
EP2717804A4 (en) * | 2011-06-06 | 2014-11-05 | Univ Utah Res Found | PERCUTANEOUS-INTEGRATED PROSTHETIC IMPLANT SYSTEM |
AU2012316698B2 (en) * | 2011-06-06 | 2015-03-26 | University Of Utah Research Foundation | Percutaneous osseointegrated prosthetic implant system |
US11298231B2 (en) | 2011-06-06 | 2022-04-12 | Joseph A. Longo | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
CN103764072A (en) * | 2011-06-06 | 2014-04-30 | 犹他大学研究基金会 | Percutaneous osseointegrated prosthetic implant system |
US20140195002A1 (en) * | 2011-06-06 | 2014-07-10 | University Of Utah Research Foundation | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
WO2013048589A1 (en) | 2011-06-06 | 2013-04-04 | University Of Utah Research Foundation | Percutaneous osseointegrated prosthetic implant system |
EP2717804A1 (en) * | 2011-06-06 | 2014-04-16 | University Of Utah Research Foundation | Percutaneous osseointegrated prosthetic implant system |
US12064350B2 (en) | 2011-06-06 | 2024-08-20 | Joseph A. Longo | Percutaneous osseointegrated implant assembly for use in supporting an exo-prosthesis |
ITFI20110158A1 (en) * | 2011-07-29 | 2013-01-30 | Erik Cocchetti | SYSTEM OF CALCINABLE COMPONENTS TO REALLIZE THE MEANS OF CONNECTION OF ORTHOPEDIC PROSTHESIS TO BONE TO WHICH THEY ARE INTENDED AND A METHOD FOR ITS REALIZATION. |
US9839535B2 (en) | 2012-07-20 | 2017-12-12 | University Of Utah Research Foundation | Modular prosthetic abutment system |
US10588761B2 (en) | 2012-07-20 | 2020-03-17 | University Of Utah Research Foundation | Modular prosthetic abutment system |
EP2967919A4 (en) * | 2013-03-15 | 2016-11-23 | Ohio Willow Wood Co | Additive manufacturing produced prosthetic foot |
US9308103B1 (en) | 2013-08-20 | 2016-04-12 | David T. Kluger | Osseointegrated mount for prosthetic limb and peripheral nerve interface |
US10342554B2 (en) | 2016-06-17 | 2019-07-09 | Socovar, L.P. | Limb sparing in mammals using patient-specific endoprostheses and cutting guides |
US10792154B2 (en) | 2016-06-17 | 2020-10-06 | Socovar, L.P. | Limb sparing in mammals using patient-specific endoprostheses and cutting guides |
US12256959B2 (en) | 2017-08-07 | 2025-03-25 | Mt Innovations, Llc. | Orthopaedic fixation assembly, system, and method of use |
EP3664725B1 (en) * | 2017-08-07 | 2024-06-12 | MT Innovations, LLC. | Orthopaedic fixation assembly, system, and method of use |
US11730520B2 (en) | 2017-08-07 | 2023-08-22 | Mt Innovations, Llc. | Orthopaedic fixation assembly, system, and method of use |
RU185647U1 (en) * | 2018-06-26 | 2018-12-13 | Общество С Ограниченной Ответственностью "Предприятие "Сенсор" | Device for osseointegration of the implant in the bone of the stump of the lower limb |
WO2021009394A1 (en) * | 2019-07-12 | 2021-01-21 | Universidad Complutense De Madrid | Custom-made endoprosthesis for long bones of animals |
ES2736410A1 (en) * | 2019-07-12 | 2019-12-30 | Univ Madrid Complutense | Customized endoprosthesis for long bones of animals |
WO2021071235A1 (en) * | 2019-10-11 | 2021-04-15 | 국립암센터 | Implant for amputated bone having mesh flange for directly connecting prosthesis to skeleton |
KR102287458B1 (en) | 2019-10-11 | 2021-08-09 | 국립암센터 | Amputation osseous implant with mesh flange for direct prosthesis limb attachment |
KR20210043329A (en) * | 2019-10-11 | 2021-04-21 | 국립암센터 | Amputation osseous implant with mesh flange for direct prosthesis limb attachment |
WO2021139915A1 (en) * | 2020-01-09 | 2021-07-15 | Adler Ortho S.P.A. | Orthopedic implant with diaphyseal and/or metaphyseal filling |
IT202000000196A1 (en) * | 2020-01-09 | 2021-07-09 | Adler Ortho S P A | Improved orthopedic implant with diaphyseal and / or metaphyseal filling. |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009105535A1 (en) | Transcutaneous osseointegrated device for prostheses | |
KR101764605B1 (en) | Prosthesis | |
CA2764495C (en) | Tissue integration design for seamless implant fixation | |
EP2563281B1 (en) | Prosthesis | |
EP2717804B1 (en) | Percutaneous osseointegrated prosthetic implant system | |
JP6554166B2 (en) | Osseo Integration-capable device | |
Park | Orthopedic prosthesis fixation | |
Spector et al. | Porous polymers for biological fixation. | |
WO2012072111A1 (en) | Orthopaedic implant | |
Al Muderis | Osseointegration for Amputees: Past, Present and Future: Basic Science, Innovations in Surgical Technique, Implant Design and Rehabilitation Strategies | |
WO2013064832A1 (en) | Prosthesis | |
ALBREKTSSON | Non-Cemented Implants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09712356 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07.02.2011) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09712356 Country of ref document: EP Kind code of ref document: A1 |